Analgesic efficacy and safety of parecoxib-sodium in patients undergoing laparoscopic cholecystectomy
10.3760/cma.j.issn.1673-4904.2010.36.002
- VernacularTitle:帕瑞昔布钠对腹腔镜胆囊切除术后的镇痛作用及安全性研究
- Author:
Yu LI
;
Liuqing WU
;
Zheng LIN
;
Jinlong WANG
;
Jianwei XU
;
Haiying JIANG
;
Chengwu ZHU
- Publication Type:Journal Article
- Keywords:
Cholecystectomy,laparoscopic;
Analgesia;
Treatment outcome;
Parecoxib-sodium
- From:
Chinese Journal of Postgraduates of Medicine
2010;33(36):3-5
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the analgesic efficacy and safety of parecoxib-sodium in patients undergoing laparoscopic cholecystectomy. Methods Ninety patients received laparoscopic cholecystectomy were divided into parecoxib-sodium group,flurbiprofen group and control group by random digits table, 30 cases in each group, all patients received the drug by vein 30 minutes before surgery. The postoperative pain intensity (VAS score), satisfaction of patients, changes of blood coagulation function and maximum agglutination rate (MAR) of platelet agglutination test before and after treatment and the incidence of postoperative adverse reaction were observed and compared. Results Pestoperative VAS scores and psychiatric symptoms at different time in parecoxib-sodium group and flurbiprofen group were significantly lower than those in control group (P ＜ 0.05), analgesic satisfaction rate were 93.3% (28/30) in parecoxibsodium group and 90.0% (27/30) in flurbiprofen group, which were significantly higher than that in control group [20.0%(6/30)] (P＜0.05). There were no significant difference in blood coagulation function and MAR before and after treatment among three groups (P ＞ 0.05). Conclusion Parecoxib-sodium displays significant analgesic effects and low rate of adverse events for the patients undergoing laparoscopic cholecystectomy, it is worthy of clinical application.
